Introduction: This report reflects a retrospective comparison among historical series of patients with similar site and stage of disease treated by three fractionation schemes. Materlals and Methods. A hyperfractionation (HF) scheme delivered 1 Gy three times a day, 5 days a week, to a total dose of 60 to 63 Gy over 26 to 29 days. A group of 48 patients received HF. Accelerated fractionation (AF) consists of 2 Gy three times a day, 5 days a week, to a total of 48 to 52 Gy delivered over 11 to 12 days. A group of 46 patients underwent this therapy. A third group of 48 patients were treated with conventional fractionation (CF). These patients received 2 Gy each day, 5 days a week, to a total dose of 60 to 66 Gy. Results: Ned survival at 5 years was 23.8%, 32.8%, and 29.3% for CF, AF, and HF, respectively. The most important cause of failure was inability to control disease at the primary site; however, isolated distant metastasis were observed in 15.4% of all failures. Treatment delays were more common in the HF and CF groups. The highest incidence of late complications occurred in the AF group. Conclusions: Advanced lesions of the oropharynx have an ominous prognosis. New fractionation regimens represent a warranted approach as an alternative to or an integration into combined chemotherapy and radiotherapy.
|Number of pages||7|
|Journal||American Journal of Otolaryngology - Head and Neck Medicine and Surgery|
|Publication status||Published - 1993|
ASJC Scopus subject areas